Home
→
Researchers
→

Élisabeth Maillart

Researcher

Élisabeth Maillart

Persistent identifiers

References for this unit in public registries: they allow cross-checking with other sources and do not change when the name does.

Affiliation

Fields of expertise

Fingolimod
Natalizumab
Anti-CD20
Multiple sclerosis
disease-modifying
Biotin
Myelin Oligodendrocyte Glycoprotein
discontinuation

22 publications in HAL since 2022.

Data provenance

Sources : scanR, HAL. Data compiled on 27/10/2026. Found an error? It is corrected in the original source (HAL, RNSR, directory); see how.